Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms

Several randomized controlled trials have demonstrated the benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on ischemic stroke in patients with diabetes. In this review, we summarize and discuss the potential mechanisms of stroke protection by GLP-1RAs. GLP-1RAs exert multiple anti-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergès, Bruno, Aboyans, Victor, Angoulvant, Denis, Boutouyrie, Pierre, Cariou, Bertrand, Hyafil, Fabien, Mohammedi, Kamel, Amarenco, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667639/
https://www.ncbi.nlm.nih.gov/pubmed/36380358
http://dx.doi.org/10.1186/s12933-022-01686-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667639/
https://www.ncbi.nlm.nih.gov/pubmed/36380358
http://dx.doi.org/10.1186/s12933-022-01686-3

Ejemplares similares